Literature DB >> 3219488

Biphasic effects of intra-accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors.

L J Bristow1, G W Bennett.   

Abstract

1. The effect of intra-accumbens injection of histamine and related compounds on the spontaneous motor activity of the rat has been investigated. 2. Microinjections of histamine (1-200 micrograms) induced dose-dependent, biphasic changes in rat activity consisting of an initial brief hypoactivity response followed by a marked hyperactivity phase. The histamine metabolite, n-tele-methylhistamine was without effect. 3. Pretreatment with the H1-receptor antagonist mepyramine (10 micrograms) blocked the hypoactivity response and markedly attenuated histamine-induced hyperactivity. In contrast, pretreatment with the H2-receptor antagonist SKF93479 had no effect on histamine-induced behaviour. 4. Microinjection of the H1-receptor agonist 2-thiazolylethylamine induced a marked hyperactivity response, but unlike the response to histamine, there was no initial hypoactivity. The H2-receptor agonist dimaprit had no apparent behavioural effects following intra-accumbens injection. 5. Intra-accumbens injection of the non-selective histamine agonists n alpha-methylhistamine or n alpha, n alpha-dimethylhistamine induced both marked hypoactivity and hyperactivity responses which were comparable with the effects of histamine. 6. The present results demonstrate a histamine, H1-receptor-mediated arousal in the nucleus accumbens which follows transitory hypoactivity, possibly due to activation of presynaptic H3-receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219488      PMCID: PMC1854284          DOI: 10.1111/j.1476-5381.1988.tb11767.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

Review 1.  Histaminergic mechanisms in brain.

Authors:  J C Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Correlation between plasma diphenhydramine level and sedative and antihistamine effects.

Authors:  S G Carruthers; D W Shoeman; C E Hignite; D L Azarnoff
Journal:  Clin Pharmacol Ther       Date:  1978-04       Impact factor: 6.875

3.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

4.  Formation and fate of histamine in rat and mouse brain.

Authors:  R W Schayer; M A Reilly
Journal:  J Pharmacol Exp Ther       Date:  1973-01       Impact factor: 4.030

5.  Inhibition of histamine-N-methylation by some antihistamines.

Authors:  K J Netter; K Bodenschatz
Journal:  Biochem Pharmacol       Date:  1967-08       Impact factor: 5.858

6.  Turnover of histamine in rat brain and its decrease under barbiturate anesthesia.

Authors:  H Pollard; S Bischoff; J C Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1974-07       Impact factor: 4.030

Review 7.  Metabolism and functions of histamine in the brain.

Authors:  J C Schwartz; G Barbin; M Baudry; M Garbarg; M P Martres; H Pollard; M Verdiere
Journal:  Curr Dev Psychopharmacol       Date:  1979

8.  Modifications of brain HA metabolism induced by antihistamines.

Authors:  H Pollard; S Bischoff; J C Schwartz
Journal:  Agents Actions       Date:  1973-10

9.  The use of Doppler shift radar to monitor physiological and drug induced activity patterns in the rat.

Authors:  C A Marsden; B King
Journal:  Pharmacol Biochem Behav       Date:  1979-05       Impact factor: 3.533

10.  The effects of prenylamine on single ventricular myocytes of guinea-pig.

Authors:  Y Shimoni; P Posner; A J Spindler; D Noble
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

View more
  10 in total

Review 1.  Plenary lecture. A third histamine receptor subtype: characterisation, localisation and functions of the H3-receptor.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard
Journal:  Agents Actions       Date:  1990-04

2.  Effect of chronic intra-accumbens administration of the TRH analogue CG3509 on histamine-induced behaviour in the rat.

Authors:  L J Bristow; G W Bennett
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

3.  Histamine depolarizes cholinergic interneurones in the rat striatum via a H(1)-receptor mediated action.

Authors:  M I Bell; P J Richardson; K Lee
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

4.  Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat.

Authors:  Catherine Pillot; Jordi Ortiz; Anne Héron; Sophie Ridray; Jean-Charles Schwartz; Jean-Michel Arrang
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

5.  Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors.

Authors:  A E Fleckenstein; K J Lookingland; K E Moore
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

Review 6.  Safety of antihistamines in children.

Authors:  A P Ten Eick; J L Blumer; M D Reed
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 7.  Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Motohiko Takemura
Journal:  Drug Target Insights       Date:  2016-03-02

Review 8.  Histamine and the striatum.

Authors:  J Paul Bolam; Tommas J Ellender
Journal:  Neuropharmacology       Date:  2015-08-11       Impact factor: 5.250

Review 9.  Histaminergic afferent system in the cerebellum: structure and function.

Authors:  Bin Li; Jing-Ning Zhu; Jian-Jun Wang
Journal:  Cerebellum Ataxias       Date:  2014-06-16

10.  Histamine H3 Receptor Function Biases Excitatory Gain in the Nucleus Accumbens.

Authors:  Kevin M Manz; Jennifer C Becker; Carrie A Grueter; Brad A Grueter
Journal:  Biol Psychiatry       Date:  2020-08-06       Impact factor: 13.382

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.